Hydra Biosciences Raises $22 Million in Series D Financing
16.01.2009 - 13:32
Hydra Biosciences,a Cambridge,Mas.-based developer of novel ion channel drugs,raised $22 million in Series D financing led by MedImmune Ventures.Prior investors contributing follow-on commitments include Advanced Technology Ventures,Abingworth,Polaris,BioVenture Investors,Biogen-Idec Ventures,and Li [...]